{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:07:31Z","timestamp":1784088451861,"version":"3.55.0"},"reference-count":30,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Objectives: Although transudative pleural effusions are generally associated with benign conditions, a subset may represent malignant pleural effusions (MPE). Because pleural fluid cytology is often not performed in transudative effusions, malignancy may be underdiagnosed. We aimed to identify predictors of malignancy in transudative pleural effusions and develop a clinical prediction score. Methods: We conducted a retrospective cohort study including patients with transudative pleural effusion who underwent pleural fluid cytological analysis between January 2022 and January 2026 at a tertiary chest diseases center. Among 3253 patients who underwent thoracentesis, 314 patients with transudative pleural effusions were included. Clinical, radiological, laboratory, and pleural fluid characteristics were analyzed. Univariable and multivariable logistic regression analyses were performed to identify independent predictors of MPE. A simplified risk score was developed from the final multivariable model and internally validated using bootstrap resampling. Results: Among 314 patients, 24 (7.6%) were diagnosed with MPE. In multivariable analysis, pleural pathology on thoracic computed tomography (CT) (OR 7.07, 95% CI 2.61\u201319.16), parenchymal nodule\/mass OR 5.18, 95% CI 1.85\u201315.54), pleural fluid lactate dehydrogenase (LDH) &gt; 150 U\/L (OR 5.09, 95% CI 1.86\u201313.93), and pleural fluid glucose &lt; 100 mg\/dL (OR 3.52, 95% CI 1.12\u201311.1) were independent predictors of MPE. The 16-point scoring system showed excellent discriminative performance (AUC 0.89). Bootstrap validation confirmed good calibration and model robustness. Conclusions: In patients with transudative pleural effusions, pleural pathology on thoracic CT, parenchymal nodule or mass, pleural fluid LDH &gt; 150 U\/L, and pleural fluid glucose &lt; 100 mg\/dL were independent predictors of MPE. A simple 16-point prediction score derived from these variables demonstrated excellent discriminative performance and may assist in identifying patients who warrant pleural fluid cytological evaluation despite transudative pleural fluid characteristics.<\/jats:p>","DOI":"10.3390\/jcm15145458","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:53:58Z","timestamp":1783932838000},"page":"5458","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting Malignancy in Transudative Pleural Effusions"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5457-9551","authenticated-orcid":false,"given":"Celal","family":"Satici","sequence":"first","affiliation":[{"name":"Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, 34020 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5101-5956","authenticated-orcid":false,"given":"Furkan","family":"Atasever","sequence":"additional","affiliation":[{"name":"Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, 34020 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9147-8602","authenticated-orcid":false,"given":"Banu","family":"Kahriman","sequence":"additional","affiliation":[{"name":"Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, 34020 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9588-4679","authenticated-orcid":false,"given":"Melis Ece","family":"Terzioglu","sequence":"additional","affiliation":[{"name":"Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, 34020 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0657-0392","authenticated-orcid":false,"given":"Seda","family":"Tural","sequence":"additional","affiliation":[{"name":"Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, 34020 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinem Nedime","family":"Sokucu","sequence":"additional","affiliation":[{"name":"Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, University of Health Sciences, 34020 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.mcna.2011.08.005","article-title":"Pleural effusions","volume":"95","author":"Light","year":"2011","journal-title":"Med. Clin. N. Am."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"h4520","DOI":"10.1136\/bmj.h4520","article-title":"The modern diagnosis and management of pleural effusions","volume":"351","author":"Bhatnagar","year":"2015","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1378\/chest.113.5.1302","article-title":"Cytologically proved malignant pleural effusions: Distribution of transudates and exudates","volume":"113","author":"Assi","year":"1998","journal-title":"Chest"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1378\/chest.104.2.399","article-title":"Evaluation of different criteria for the separation of pleural transudates from exudates","volume":"104","author":"Romero","year":"1993","journal-title":"Chest"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.109.6.1503","article-title":"A Study of Light\u2019s Criteria and Possible Modifications for Distinguishing Exudative from Transudative Pleural Effusions","volume":"109","author":"Vives","year":"1996","journal-title":"Chest"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1378\/chest.74.6.640","article-title":"The significance of a cytologically negative pleural effusion in bronchogenic carcinoma","volume":"74","author":"Decker","year":"1978","journal-title":"Chest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1378\/chest.114.6.1798-a","article-title":"Positivity of pleural fluid cytologic examination in transudative pleural effusions","volume":"114","author":"Foresti","year":"1998","journal-title":"Chest"},{"key":"ref_8","first-page":"846","article-title":"Cytology on transudative pleural effusions","volume":"116","author":"Teklu","year":"1999","journal-title":"Chest. Am. Coll. Chest Physicians"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.21037\/jtd.2017.01.12","article-title":"Predictive models of malignant transudative pleural effusions","volume":"9","author":"Ferreiro","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_10","first-page":"1836","article-title":"Should a cytologic study be ordered in transudative pleural effusions?","volume":"116","author":"Porcel","year":"1999","journal-title":"Chest. Am. Coll. Chest Physicians"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0272-5231(21)00337-3","article-title":"Transudative pleural effusions","volume":"6","author":"Chetty","year":"1985","journal-title":"Clin. Chest Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1378\/chest.114.6.1798","article-title":"Cytologically proved malignant pleural effusions","volume":"114","author":"Castro","year":"1998","journal-title":"Chest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3904\/kjim.2003.18.4.230","article-title":"What is the clinical significance of transudative malignant pleural effusion?","volume":"18","author":"Ryu","year":"2003","journal-title":"Korean J. Intern Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.21037\/atm.2019.09.85","article-title":"Diagnostic accuracy of cancer ratio for malignant pleural effusion: A systematic review and meta-analysis","volume":"7","author":"Han","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_15","first-page":"221","article-title":"Value of Cancer Ratio plus and Cancer Ratio Formulation in Distinguishing Malignant Pleural Effusion from Tuberculosis and Parapneumonic Effusion","volume":"20","author":"Gayaf","year":"2021","journal-title":"Tanaffos"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9343(01)00726-4","article-title":"Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure","volume":"110","year":"2001","journal-title":"Am. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ii4","DOI":"10.1136\/thx.2010.136978","article-title":"Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Hooper","year":"2010","journal-title":"Thorax"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1076-6332(05)80373-3","article-title":"Pleural fluid volume estimation: A chest radiograph prediction rule","volume":"3","author":"Blackmore","year":"1996","journal-title":"Acad. Radiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107854","DOI":"10.1016\/j.rmed.2024.107854","article-title":"Prognostic role of pleural fluid SUVpeak value obtained from 18F-FDG PET\/CT in patients with malignant pleural effusion","volume":"236","author":"Atasever","year":"2025","journal-title":"Respir. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4081\/monaldi.2005.653","article-title":"CT in differential diagnosis of benign and malignant pleural disease","volume":"63","author":"Yilmaz","year":"2005","journal-title":"Monaldi Arch. Chest Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjmed.2006.05.066","article-title":"Diagnostic and therapeutic approach to acute decompensated heart failure","volume":"120","author":"Kapoor","year":"2007","journal-title":"Am. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00063198-199807000-00011","article-title":"Hepatic hydrothorax","volume":"4","author":"Xiol","year":"1998","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/0003-4819-77-4-507","article-title":"Pleural effusions: The diagnostic separation of transudates and exudates","volume":"77","author":"Light","year":"1972","journal-title":"Ann. Intern Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMcp010731","article-title":"Clinical practice. Pleural effusion","volume":"346","author":"Light","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_26","first-page":"1211","article-title":"Diagnostic approach to pleural effusion in adults","volume":"73","author":"Porcel","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"ref_27","first-page":"113","article-title":"Puntos de corte de los par\u00e1metros bioqu\u00edmicos del l\u00edquido pleural: Su utilidad en el diagn\u00f3stico diferencial de 1.040 pacientes con derrame pleural [Cuttoff values of biochemical tests on pleural fluid: Their usefulness in differential diagnosis of 1040 patients with pleural effusion]","volume":"21","year":"2004","journal-title":"An. Med. Interna"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/10408363.2025.2559697","article-title":"Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: A clinical review","volume":"63","author":"Santotoribio","year":"2026","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1164\/ajrccm\/139.3.663","article-title":"Low glucose and pH levels in malignant pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis","volume":"139","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101800","DOI":"10.1016\/j.tranon.2023.101800","article-title":"Clinical identification of malignant pleural effusions","volume":"39","author":"Jia","year":"2024","journal-title":"Transl. Oncol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5458\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T03:35:52Z","timestamp":1784086552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/14\/5458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":30,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["jcm15145458"],"URL":"https:\/\/doi.org\/10.3390\/jcm15145458","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]}}}